Form 8-K - Current report:
SEC Accession No. 0001070081-17-000082
Filing Date
2017-05-08
Accepted
2017-05-08 07:42:35
Documents
7
Period of Report
2017-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K may_8x8kx101x202x203x901.htm 8-K 60884
2 EXHIBIT 10.1 a101_creditagreement1.htm EX-10.1 875665
3 EXHIBIT 10.2 a102_pledgeagreement.htm EX-10.2 102059
4 EXHIBIT 10.3 a103_ipsecurityagreement.htm EX-10.3 22652
5 EXHIBIT 99.1 a2017-05x08ptct1qpr.htm EX-99.1 115096
6 a20170508ptct1qprimage1.jpg GRAPHIC 6428
7 camidcap.jpg GRAPHIC 16108
  Complete submission text file 0001070081-17-000082.txt   1209057
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 17820596
SIC: 2834 Pharmaceutical Preparations